by Marcia Schekel
A diagnosis … mesothelioma … a punch to the gut … frozen with fear.
Mine was April 2014: surgical biopsy, pleural mesothelioma (epithelioid), inoperable, stage 4.
What is this strange disease? I ‘google’ meso, lawyers call. Arghhh. Somehow I contact the Meso Foundation, Mary calls. I know I am connected with others with meso. I […]
by Marcia Schekel
On April 26, we had the opportunity to attend Bloomberg Government’s conference on Building the Big Data Economy: Personalized care and cancer treatment in the age of big data. The conference centered around two main topics: the Precision Medicine Initiative (PMI) and the Cancer Moonshot Initiative (CMI).
The event kicked off with a conversation about precision […]
On April 12, Friends of Cancer Research held a briefing on Capitol Hill on the topic of Breakthrough Therapy Designation: Successes, Lessons Learned and Future Strategies. Through the breakthrough therapy program, which followed the passage of the Food and Drug Administration Safety and Innovation Act (FDASIA) in 2012, a new drug may be designated as […]
If you attended our International Symposium on Malignant Mesothelioma in March of this year, you may recall the buzz of excitement that coursed throughout the scientific sessions. This buzz sparked excitement throughout the entire mesothelioma community, as we discussed advances in science, the needs of those affected by this disease, and the work being done […]
by Aria and Bella Bendix, Rising Leaders Council, Mesothelioma Applied Research Foundation. In memory of Ken Bendix, their father.
Father’s Day is a complicated day for the two of us. Every year as the third week in June approaches and the TV floods with Father’s Day commercials, or “Gifts for Dad” begin to appear in the […]